Dr. Neil Pravin Shah, MD

Dr. Shah practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Shah's NPI, 1881614873, was assigned on July 20, 2006. Dr. Shah graduated from David Geffen School of Medicine at UCLA in 1996. Dr. Shah holds California license A65055.

Dr. Shah's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Shah's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Shah to 3 more medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shah practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Shah's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Shah is board certified in hematology by the American Board of Internal Medicine. Dr. Shah is licensed in California.

Dmand AI lists chronic leukemia among the conditions Dr. Shah treats.

CMS data shows 249 Medicare services from Dr. Shah across 2 procedure codes in 2024, for 59 Medicare patients. Medicare paid $17,532 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 59 Medicare patients who saw Dr. Shah in 2024. The largest group is 65 to 74, with 33 patients. 66% of them have high blood pressure, and 61% have high cholesterol. 29% are also on Medicaid. Their average risk score is 2.17, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shah's median patient age at 62, with 47% women.

In 2024, Dr. Shah wrote 431 Medicare Part D claims for 50 patients. 13% of them were for generic drugs. CMS names the drug for 390 of them, across 5 drugs with 11 or more claims each, at $4,208,986 in total drug cost. In 2023, CMS named 373 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Shah for performance year 2024, reported as part of a group. Dr. Shah accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Shah as offering telehealth.

Dmand AI links 4 papers to Dr. Shah.

CMS Open Payments shows 9 general payments to Dr. Shah from 7 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 96% of the total. Taiho Oncology, Inc. paid the most, $6,100.

Dr. Shah graduated from David Geffen School of Medicine at UCLA in 1996.

Dr. Shah is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.